Table 1 Study cohort’s general characteristics
Variables | Overall cohort (n = 145) |
|---|---|
Age (years), mean (SD) | 64 (15) |
Gender, n (%) | |
Males | 86 (59%) |
Body mass index (kg/m2), mean (SD) | 27.6 (6) |
Comorbidities, n (%) | |
Chronic obstructive pulmonary disease | 14 (10%) |
High blood pressure | 86 (59%) |
Ischemic heart disease | 49 (34%) |
Chronic systolic heart failure | 21 (15%) |
Valvular heart disease | 37 (26%) |
Peripheral artery disease | 12 (8%) |
Diabetes on oral antidiabetics | 26 (18%) |
Diabetes on insulin | 15 (10%) |
Chronic kidney disease | 15 (10%) |
Stroke | 15 (10%) |
Medical ICU admission, n (%) | 92 (63%) |
Admission SAPS II, median [IQR] | 46 [37;59] |
Patients treated with catecholamines, n (%) | |
Norepinephrine (yes) | 63 (43%) |
Dobutamine (yes) | 11 (7%) |